Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CZR
Caesars Entertainment Corporation
CZR
|
+$30.6M |
| 2 |
IBKC
IBERIABANK Corp
IBKC
|
+$19.7M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$19.2M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$17M |
| 5 |
Marathon Petroleum
MPC
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$128M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$120M |
| 3 |
Microsoft
MSFT
|
+$39.1M |
| 4 |
Walt Disney
DIS
|
+$33.2M |
| 5 |
UBNK
United Financial Bancorp, Inc.
UBNK
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.67% |
| 2 | Technology | 16.32% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Synopsys
SNPS
$76.2B
| $2.03M | 0.09% |
+14,567
| New | +$2M |
|
277
Ally Financial
ALLY
$13.1B
| $2.03M | 0.09% |
+66,330
| New | +$2.07M |
|
278
Qualcomm
QCOM
$169B
| $2.03M | 0.09% |
22,966
-53,868
| -70% | -$4.51M |
|
|
S
279
DELISTED
Sprint Corporation
S
| $2.02M | 0.09% |
+387,814
| New | +$2.27M |
|
280
Tractor Supply
TSCO
$18.2B
| $2.02M | 0.09% |
107,815
-384,630
| -78% | -$7.3M |
|
281
Ventas
VTR
$47.7B
| $2.02M | 0.09% |
+34,906
| New | +$2.19M |
|
282
Thermo Fisher Scientific
TMO
$233B
| $2.01M | 0.09% |
+6,182
| New | +$1.87M |
|
|
PTLA
283
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2M | 0.09% |
83,891
+1,103
| +1% | +$30.4K |
|
284
BrightView Holdings
BV
$1.05B
| $1.99M | 0.09% |
118,222
+2,206
| +2% | +$38.4K |
|
285
Fidelity National Financial
FNF
$12.7B
| $1.98M | 0.09% |
+45,502
| New | +$2.02M |
|
286
8x8 Inc
EGHT
$290M
| $1.98M | 0.09% |
108,102
+58,428
| +118% | +$1.13M |
|
287
Parker-Hannifin
PH
$126B
| $1.97M | 0.09% |
+9,591
| New | +$1.86M |
|
288
Stryker
SYK
$126B
| $1.97M | 0.09% |
+9,363
| New | +$1.94M |
|
289
Match Group
MTCH
$9.38B
| $1.95M | 0.09% |
23,795
-102,210
| -81% | -$7.43M |
|
|
BHVN
290
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.95M | 0.09% |
35,814
+21,216
| +145% | +$1.05M |
|
291
Qualys
QLYS
$6.3B
| $1.95M | 0.09% |
23,364
+20,373
| +681% | +$1.69M |
|
292
EOG Resources
EOG
$80.3B
| $1.93M | 0.09% |
23,044
-42,740
| -65% | -$3.13M |
|
293
UDR
UDR
$12.1B
| $1.93M | 0.09% |
41,326
-18,116
| -30% | -$870K |
|
294
Corcept Therapeutics
CORT
$13.2B
| $1.93M | 0.09% |
159,454
-15,908
| -9% | -$221K |
|
|
MSGN
295
DELISTED
MSG Networks Inc.
MSGN
| $1.93M | 0.09% |
110,675
-55
| -0% | -$915 |
|
296
CoStar Group
CSGP
$13.1B
| $1.92M | 0.09% |
32,040
+2,440
| +8% | +$142K |
|
297
Gentex
GNTX
$4.98B
| $1.92M | 0.09% |
66,145
-173,244
| -72% | -$4.88M |
|
298
Acadia Pharmaceuticals
ACAD
$5.08B
| $1.92M | 0.09% |
44,793
-90,572
| -67% | -$3.94M |
|
299
Upwork
UPWK
$1.08B
| $1.92M | 0.09% |
179,458
+94,415
| +111% | +$1.19M |
|
300
Regeneron Pharmaceuticals
REGN
$85.9B
| $1.91M | 0.09% |
+5,096
| New | +$1.71M |
|
Similar funds
Paul Tudor Jones's Q4 2019 Portfolio in Review
As of Q4 2019, Paul Tudor Jones held 1,507 positions worth $2.23B, down 23% from $2.91B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Paul Tudor Jones withdrew a net $828M in Q4 2019, closing 396 positions and reducing 383 holdings. Its most notable exit was Celgene Corp, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Paul Tudor Jones opened a new position in Caesars Entertainment Corporation worth $32.9M.
- Paul Tudor Jones's largest Q4 2019 buy was Caesars Entertainment Corporation: 2,416,136 shares worth $32.9M.
- Paul Tudor Jones added most to eBay in Q4 2019, an estimated $14.6M increase.
- Paul Tudor Jones's biggest Q4 2019 reduction was Microsoft, cutting an estimated $39.1M.
- Paul Tudor Jones fully exited Celgene Corp in Q4 2019, selling an estimated $128M.
- Paul Tudor Jones's ten largest holdings make up 20% of its $2.23B portfolio in Q4 2019.
- Paul Tudor Jones opened 458 new positions and closed 396 in Q4 2019.
- Paul Tudor Jones's portfolio value fell 23% quarter-over-quarter to $2.23B.
Based on Tudor Investment Corp's 13F filing for Q4 2019, filed 14 Feb 2020.